Printer-friendly version
EPISCAN I-200 high frequency ultrasound technology alerts clinicians to subtle non-visual tissue damage at the time of admission and provides documentation.
• Non-invasive imaging of all wounds
• Early detection of pressure ulcers
• Skin assessment aid
• Enhanced documentation
Store at room temperature.
| 3D measurement | |
| Automated alert notifications on wound status | |
| Data export | |
| Diagnostic capabilities | |
| Digital imaging | ● |
| HIPAA compliant | |
| Non-contact | |
| Progress tracking | |
| Reference/resource availability | |
| Reporting capabilities | |
| Smart device enabled | |
| Software-integrated | |
| System hardware components |
| Educational Material Available | ● |
| Free Samples/Trials Available | |
| Published Clinical Article Available | ● |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Dermatology
Diabetic Foot
Granulating/Epithelializing Wounds
Hypertrophic Scars/Keloids
Infected Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Palliative Wounds
Pressure Ulcers
Sloughy Wounds
Superficial Wounds
Surgical Wounds
Traumatic Wounds
Venous Ulcers
EPISCAN I-200 is for use with skin assessment upon admission and for ongoing use to assess wounds and the impact of treatments.
One year limited, after that there is the option to purchase an extension
Supplied upon request.
Longport, Inc. develops high resolution ultrasound imaging systems, such as the EPISCAN I-200 which can have connected to it a range of interchangeable imaging probes that enable imaging of the skin.